3 Kenneth M. Hemodynamic effects of PGE1 in patients with congenital heart disease and pulmonary hypertension. Cath and Cardiovascular Diagnosis, 1991,24:10-15.
4 Sakaguchi K, Tanaka N, Savada N, et al. Vasodilator therapy for right ventricular failure. Jpn Cire J, 1984,48:357-364.
5 D'Ambra MN, LaRaia PJ, Phulbin DM, et al. Prostaglandin E1: a new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg, 1985,89:567-572.
6 Pallapics D, Pekar BA. Effect of PGE1 and its initial metabolites on neutrophilinduced inhibition of human platelet aggregation. Thrombosis Research, 1993,71:217-225.
7 Holcroft JW, Vassar MJ, Weber CJ. PGE1 and survival in patients with the ARDS. Ann Surg, 1986,203:371-378.